Clinical Trial Update: Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating rosiglitazone added to insulin in adults with Type 2 diabetes inadequately controlled on insulin; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED